What is the NOAEL for 13-cis Retinoic acid?
13-cis Retinoic acid has 9 NOAEL studies in the database. The lowest reported value is developmental listing type. Source: California Proposition 65.
Also known as: Isotretinoin, (13Z)-Retinoic acid, 13-cis-Vitamin A acid, 13-cis-beta-Retinoic acid, 13-cis-retinoic acid (+14 more)
CAS 4759-48-2
13-cis Retinoic acid (CAS 4759-48-2) is a chemical substance; key hazard signal: developmental. Key regulatory status: California Proposition 65, 4 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, CA Prop 65.
13-cis Retinoic acid is classified GHS Danger (H315, H319, H335, H360, H400, H410) in the chemicals database but is allowed in EU cosmetics at max 45%.
CAS, identifiers, formula, and alternate names for the matched substance record.
California OEHHA listing status and toxicity category.
| Chemical | Toxicity Type | Cancer | Developmental | Listed |
|---|---|---|---|---|
| - | developmental | No | Yes | - |
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| pharmaceutical | US International Trade Commission | CPCat |
| OEHHA Proposition 65 (3/2019) | STATE OF CALIFORNIA ENVIRONMENTAL PROTECTION AGENCY | OEHHA Proposition 65 List |
| Canada; pharmaceutical | DrugBank | DrugBank |
| OEHHA Proposition 65 (1/2023) | California Office of Environmental Health Hazard Assessment | OEHHA Proposition 65 List |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| SQEdevelopmental | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| SQEdevelopmental | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| SQEdevelopmental | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| SQEdevelopmental | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| EH28UP18IF | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| EH28UP18IF | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| EH28UP18IF | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| EH28UP18IF | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| >4000 | mg/kg bw | LD50 | oral | Rat | NTP_ICE_acute_oral |
Showing 9 of 9 studies
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
13-cis Retinoic acid has 9 NOAEL studies in the database. The lowest reported value is developmental listing type. Source: California Proposition 65.
13-cis Retinoic acid appears on 4 regulatory/inventory lists including pharmaceutical, OEHHA Proposition 65 (3/2019), Canada; pharmaceutical, and 1 more. Source: EPA CPDat.
Yes, 13-cis Retinoic acid is listed under California Proposition 65 for developmental. Source: California OEHHA Proposition 65.
Yes, 13-cis Retinoic acid is also indexed as a cosmetic ingredient under the name Isotretinoin Regulatory. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, EPA DSSTox, California Proposition 65, CosIng / Ingredients DB, ChEMBL / DailyMed. All data traces to primary regulatory sources and is updated from official government databases.
13-cis Retinoic acid is classified GHS Danger (H315, H319, H335, H360, H400, H410) in the chemicals database but is allowed in EU cosmetics at max 45%.
13-cis Retinoic acid also appears in cosmetics, pharmaceutical databases.